A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers

Clinical trial NCT06852976 · RECRUITING

Trial details

NCT number: NCT06852976
Sponsor: Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Foot Ulcer

Start date: 2025-03-12
Primary completion: 2025-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.